Hepatic Filling Rate of a Microbubble Agent: A Novel Predictor of Long-Term Outcomes in Patients With Cirrhosis

Ultrasound in Medicine and Biology

Volumn 40, Issue 9, 2014, Pages 2082-2088

  Sekimoto, Tadashi ^a   Maruyama, Hitoshi ^a   Kiyono, Soichiro ^a   Kondo, Takayuki ^a   Shimada, Taro ^a   Ishibashi, Hiroyuki ^a   Takahashi, Masanori ^a   Yokosuka, Osamu ^a   Yamaguchi, Tadashi ^b  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Cirrhosis; Contrast enhanced ultrasound; Hepatocellular carcinoma; Long term survival; Portal hypertension

Indexed keywords

DIAGNOSIS; LIVER;

CIRRHOSIS; CONTRAST ENHANCED ULTRASOUND; HEPATOCELLULAR CARCINOMA; LONG-TERM SURVIVAL; PORTAL HYPERTENSION;

FILLING;

PERFLUBUTANE; CONTRAST MEDIUM; FLUOROCARBON;

ADULT; AGED; ARTICLE; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; END STAGE LIVER DISEASE; FEMALE; HEPATIC ARTERY; HEPATIC FILLING RATE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER PARENCHYMA; MALE; MICROBUBBLE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; DIAGNOSTIC USE; ECHOGRAPHY; FOLLOW UP; IMAGE ENHANCEMENT; LIVER; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

ADULT; AGED; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER CIRRHOSIS; MALE; MICROBUBBLES; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84905586788     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2014.04.014     Document Type: Article

References (21)

1. Albrecht T., Blomley M.J., Cosgrove D.O., Taylor-Robinson S.D., Jayaram V., Eckersley R., Urbank A., Butler-Barnes J., Patel N. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999, 8:1579-1583.
2. Ascha M.S., Hanouneh I.A., Lopez R., Tamimi T.A., Feldstein A.F., Zein N.N. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51:1972-1978.
3. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022.
4. Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol 2006, 60:324-330.
5. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006, 44:217-231.
6. Fattovich G., Stroffolini T., Zagni I., Donato F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 2004, 127:S35-S50.
7. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., Blei A.T. Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
8. Guibal A., Bertin C., Egels S., Savier E., Grenier P.A., Lucidarme O. Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: Treated-area patterns and their changes over time. Eur Radiol 2013, 23:1392-1400.
9. Ishibashi H., Maruyama H., Takahashi M., Fujiwara K., Imazeki F., Yokosuka O. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography. Liver Int 2010, 30:1355-1363.
10. Lim A.K., Patel N., Eckersley R.J., Goldin R.D., Thomas H.C., Cosgrove D.O., Taylor-Robinson S.D., Blomley M.J. Hepatic vein transit time of SonoVue: A comparative study with Levovist. Radiology 2006, 240:130-135.
11. Maruyama H., Ishibashi H., Takahashi M., Imazeki F., Yokosuka O. Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis. Radiology 2009, 252:587-594.
12. Masuzaki R., Tateishi R., Yoshida H., Goto E., Sato T., Ohki T., Imamura J., Goto T., Kanai F., Kato N., Ikeda H., Shiina S., Kawabe T., Omata M. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009, 49:1954-1961.
13. Nissen N.N., Martin P. Hepatocellular carcinoma: The high-risk patient. J Clin Gastroenterol 2002, 35:S79-S85.
14. Ohnishi K., Sato S., Pugliese D., Tsunoda T., Saito M., Okusa K. Changes of splanchnic circulation with progression of chronic liver disease studied by echo-doppler flowmetry. Am J Gastroenterology 1987, 82:507-511.
15. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007, 17:1995-2008.
16. Quaia E. The real capabilities of contrast-enhanced ultrasound in the characterization of solid focal liver lesions. Eur Radiol 2011, 21:457-462.
17. Rettenbacher T. Focal liver lesions: Role of contrast-enhanced ultrasound. Eur J Radiol 2007, 64:173-182.
18. Staub F., Tournoux-Facon C., Roumy J., Chaigneau C., Morichaut-Beauchant M., Levillain P., Prevost C., Aubé C., Lebiqot J., Oberti F., Galtier J.B., Laumonier H., Trillaud H., Bernard P.H., Blanc J.F., Sironneau S., Machet F., Drouillard J., de Ledinghen V., Couzigou P., Foucher P., Castéra L., Tranquard F., Bacq Y., d'Altéroche L., Ingrand P., Tasu J.P. Liver fibrosis staging with contrast-enhanced ultrasonography: Prospective multicenter study compared with METAVIR scoring. Eur Radiol 2009, 19:1991-1997.
19. Tandon P., Garcia-Tsao G. Portal hypertension and hepatocellular carcinoma: Prognosis and beyond. Clin Gastroenterol Hepatol 2006, 4:1318-1319.
20. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H., Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993, 328:1797-1801.
21. Williams R. Global challenges in liver disease. Hepatology 2006, 44:521-526.